Experiences with the FACT-EGFRI-18 instrument in EGFRI-associated mucocutaneous adverse events

Author(s):
Boers-Doets, C.B.; Gelderblom, H.; Lacouture, M.E.; Epstein, J.B.; Nortier, J.W.R.; Kaptein, A.A.
Published
2013
Publication type
Article / Letter to editor
Epidermal growth factor receptor inhibitors (EGFRI)FACT-EGFRI-18Mucocutaneous adverse events (mcAE)Health-related quality of life (HRQoL)Patient-reported outcome questionnaireSymptom burden
Date issued
2013-07-31
Language
English
Is part of
Supportive Care in Cancer (2013), Vol. 21, no. 7, p. 1919-1926
hdl
1887/100094
doi
10.1007/s00520-013-1752-4